Fmoc-D-4-thiazolylalanine is a non-proteinogenic, unnatural amino acid derivative. Its structure features a thiazole heterocycle attached to the beta-carbon of an alanine backbone, which is protected at the N-terminus by a 9-fluorenylmethoxycarbonyl (Fmoc) group. The presence of the D-configuration at the alpha-carbon is a key stereochemical feature. This compound is a solid under standard conditions and is primarily handled in research and development laboratories. This amino acid building block is specifically designed for use in solid-phase peptide synthesis (SPPS) employing the Fmoc strategy. The thiazole ring is a privileged scaffold in medicinal chemistry, known to impart bioactivity and influence the conformational properties of peptides. Incorporating Fmoc-D-4-thiazolylalanine into peptide sequences allows researchers to introduce this heterocyclic motif, which can enhance binding affinity, metabolic stability, or serve as a bioisostere for other functional groups. It is therefore a critical reagent in the discovery and development of novel peptide-based therapeutics, diagnostic agents, and biochemical probes. As a specialty, non-natural amino acid, its use is highly targeted towards advanced peptide chemistry. It is not a commodity chemical and is typically sourced from fine chemical suppliers specializing in peptide synthesis reagents. Proper handling requires standard laboratory safety precautions for fine organic chemicals, including the use of personal protective equipment.